We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Guidance for bowel cancer screening providers on using national accessible format letter content to support informed choice.
Explains the NHS Diabetic Eye Screening (DES) Programme's processes for image capture exceptions and ungradable images.
Guidance on minimum specific audits that diabetic eye screening services must complete on a regular basis.
The external quality assessment (EQA) scheme for gynaecological cytopathology in the NHS cervical screening programme.
Advice on cervical screening for lesbian and bisexual women.
This document sets out the programme specific operating model (PSOM) for quality assurance of the NHS Cervical Screening Programme.
Training and continuing professional development (CPD) for people working in the newborn blood spot (NBS) screening programme in England.
Capitation is an example of a potential new payment model to enable integrated care.
An overview of the sickle cell and thalassaemia (SCT) screening end-to-end pathway.
How to use the newborn blood spot screening failsafe solution (NBSFS), the national IT system, to minimise risk to babies.
This document sets out the NHS Bowel Cancer Screening Programme's (BCSP) pathology guidelines for reporting lesions.
Easy read version of diabetic eye screening (DES) invitation letter template.
The annual cervical screening standards data report, covering 1 April 2023 to 31 March 2024.
This document explains the guidelines for laboratories screening newborns for cystic fibrosis (CF) in the UK.
Guidelines for laboratories screening newborns for congenital hypothyroidism (CHT) in the UK.
Sickle cell and thalassaemia high/low prevalence laboratory return 2024 to 2025
Guidance on how antenatal screening teams work with laboratories and sexual health services to manage a confirmed syphilis screen positive result during pregnancy.
Advice for prescribers on the risk of misuse of pregabalin and gabapentin, and suggestions for a balanced and rational use of these medicines.
Important information for women whose antenatal screening test shows they have HIV, to help explain their result.
An overview of the newborn and infant physical examination screening end-to-end pathway.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).